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I. General Information 
 
Materials. Commercial reagents were acquired from Sigma-Aldrich, Alfa Aesar, Acros, Strem, 
TCI, or Oakwood and used as received. Diethyl ether (Et2O), tetrahydrofuran (THF), and toluene 
(PhMe) were dried by passing through activated alumina columns and stored over molecular 
sieves in a N2-filled glovebox; N,N-dimethylformamide (DMF) was dried by passing through a 
column of activated molecular sieves. Acetonitrile (MeCN) was purchased from Millipore Sigma 
without sieves and subsequently sparged with nitrogen before bringing it into the glovebox. 
Sieves were detrimental for reactivity.  
 
Instrumentation. Proton nuclear magnetic resonance (1H NMR) spectra were recorded on a 
Bruker 500 AVANCE spectrometer (500 MHz), a Bruker NB 300 spectrometer (300 MHz), or a  
Bruker Avance III HD NanoBay (400 MHz) spectrometer. Deuterium nuclear magnetic reso-
nance (2H NMR) spectra were recorded on a Bruker 500 AVANCE spectrometer (77 MHz). Car-
bon nuclear magnetic resonance (13C NMR) spectra were recorded on a Bruker 500 AVANCE 
spectrometer (126 MHz). Fluorine nuclear magnetic resonance (19F NMR) spectra were rec-
orded on a Bruker NB 300 spectrometer (282 MHz). Chemical shifts for protons are reported in 
parts per million (ppm) downfield from tetramethylsilane and are referenced to residual protium 
in the NMR solvent (CHCl3 =  7.26 ppm). Chemical shifts for carbon are reported in parts per 
million downfield from tetramethylsilane and are referenced to the carbon resonances of the 
solvent residual peak (CDCl3 =  77.16 ppm). Chemical shifts for fluorine are reported in parts 
per million referenced to CFCl3 ( 0 ppm). NMR data are represented as follows: chemical shift 
( ppm), multiplicity (s = singlet, bs = broad singlet, d = doublet, appd = apparent doublet, t = 
triplet, q = quartet, p = pentet, sx = sextet m = multiplet), coupling constant in Hertz (Hz), inte-
gration. Reversed-phase liquid chromatography/mass spectrometry (LC/MS) was performed on 
an Agilent 1260 Infinity analytical LC and Agilent 6120 Quadrupole LC/MS system, using elec-
trospray ionization/atmospheric-pressure chemical ionization (ESI/APCI), and UV detection at 
254 and 280 nm. High-resolution mass spectra were obtained on an Agilent 6220 LC/MS using 
electrospray ionization time-of-flight (ESI-TOF) or Agilent 7200 gas chromatography/mass spec-
trometry using electron impact time-of-flight (EI-TOF). Gas chromatography was performed on 
an Agilent 7890A series instrument equipped with a split-mode capillary injection system and 
flame ionization detectors. Fourier transform infrared (FT-IR) spectra were recorded on a Perkin-
Elmer Spectrum 100 and are reported in terms of frequency of absorption (cm–1). High-perfor-
mance liquid chromatography (HPLC) was performed on an Agilent 1200 series instrument with 
a binary pump and a diode array detector, using Chiralcel OD-H (25 cm x 0.46 cm), Chiralcel 
OJ-H (25 cm x 0.46 cm), Chiralpak AS-H (25 cm x 0.46 cm), Chiralpak AD-H (25 cm x 0.46 cm), 
Chiralpak IC (25 cm x 0.46 cm) and Chiralpack ID (25 cm x 0.46 cm). 
 
Light Sources. Reactions were initially optimized on 34 W blue LED lamps (KSH150B Grow 
Light Blue) purchased from Kessil. When Kessil lamps were used, they were placed 2 cm away 
from 1-dram reaction vials without the use of fans. Isolations yields were obtained using a Pho-
toreactor (PR). Photoreactors were generously obtained from the MacMillan lab. A Penn OC 
Photoreactor M1 series was used with a 450 nm light source.1 
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II. Control and Optimization Studies 
 
Procedure for reaction optimization: An oven-dried 1-dram reaction vial (VWR® glass vials, 
66011-041) was charged with carboxylic acid (0.1 mmol, 1.0 equiv) and equipped with a 
PTFE-coated stir bar (VWR® Micro stir bars, 2 x 7 mm, 58948-976). The vial was Teflon taped 
on the threads, and then taken into a N2-filled glovebox. To the vial was added MeCN (0.1 M), 
alkene (0.3 mmol, 3.0 equiv) and base (0.1 mmol, 1.0 equiv). From a stock solution was added 
[Ir(dF-Me-ppy)2dtbbpy]PF6 (2 mg, 0.002 mmol, 0.02 equiv) and Ph2S2 (1.0 mg, 0.005 mmol, 
0.05 equiv). Finally, phosphine (0.1 mmol, 1.0 equiv) was added. The vial was then capped 
and sealed with electrical tape. The vial was irradiated for 24 h with 34 W blue LEDs. An ali-
quot of the crude reaction mixture was analzed by 1H-NMR with 1-fluoronaphthalene (0.1 
mmol, 1.0 equiv) as an external standard.  
 
Our initial efforts began employing 3-(4-fluorophenyl)propanoic acid with 1-(trifluoromethyl)-2-
vinylbenzene as alkene acceptor and ethyl diphenyl phosphinite as mediator.   
 
Table S1. Control and optimization of the coupling reaction between 3-(4-fluorophenyl)propa-
noic acid and 1-(trifluoromethyl)-2-vinylbenzene 
 
 
 
 
Table S2. Optimization of solvent using ethyl diphenyl phosphinite as phosphine mediator.  
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Table S3. Optimization of bases using ethyl diphenyl phosphinite as phosphine mediator.  
 
 
 
 
 
 
Given the poor success of ethyl diphenyl phosphinite in this reaction, emission quenching ex-
periments were undertaken (See Section V). More importantly, other phosphines were explored 
for this reaction. The alkene acceptor was substituted for -methyl styrene in order to bias the 
reaction toward radical addition. 
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Figure S1. Optimization of phosphines using 3-(4-fluorophenyl)propanoic acid and alpha methyl 
styrene.  
 
 
Table S4. Examination of photocatalysts.  
 
 
 
 
  
Table S5. Examination of hydrogen atom donors.  
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Table S6. Examination of phenyl disulfide loading. Yield was determined by GC-FID using 1-
fluoronaphthalene as an external standard.  
 
 
 
 
Table S7. Examination of base additives. Yield was determined by GC-FID using 1-fluoronaph-
thalene as an external standard.  
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Table S8. Optimization of Phosphine loading using methyl diphenyl phosphinite, 3-(4-fluoro-
phenyl)propanoic acid, and alpha methyl styrene.  
 
 
 
 
 
 
 
Table S9. Deoptimization table highlights the need for Iridium and phosphine for reactivity. While 
kessils provide moderate yield, Photoreactors were used because they provide a standardized 
light and temperature set up. Use of 5-cyclohexylpentanoic acid on 0.5 mmol scale without di-
phenyl disulfide results in lower yield. The yield was restored by using 2.4 equivalents of phos-
phine. Diphenyl disulfide was removed from non-polar carboxylic acids to provide an easier iso-
lation.     
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Figure S2. Poorly performing carboxylic acids when coupling with 1,1 diphenyl ethylene.  
 
 
 
 
 
 
 
Figure S3. Poorly performing alkenes when coupling with 4-fluoro hydrocinnamic acid. Morita-
Baylis Hillman reactivity was observed by GC-MS for the acrylate derivatives. 
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II. General Procedures 
 
 
General procedure A. An oven-dried 1-dram reaction vial (VWR® glass vials, 66011-041) 
was charged with carboxylic acid (0.5 mmol, 1.0 equiv) and equipped with a PTFE-coated stir 
bar (VWR® Micro stir bars, 2 x 7 mm, 58948-976). The vial was Teflon taped on the threads, 
and then taken into a N2-filled glovebox. To the vial was added MeCN (0.5 M), alkene (265 L, 
1.5 mmol, 3.0 equiv) and 2,6-lutidine (58 L, 0.5 mmol, 1.0 equiv). From a stock solution was 
added [Ir] (8.7 mg, 0.01 mmol, 0.017 equiv) and Ph2S2 (5.46 mg, 0.025 mmol, 0.05 equiv). Fi-
nally, phosphine (142 L, 1.0 mmol, 2.0 equiv) was added. The vial was then capped and 
sealed with electrical tape. The vial was irradiated for 24 h in a Photoreactor (800 rpm, 1500 
fan speed, 100% light intensity). An aliquot of the crude reaction mixture was analzed by 1H-
NMR with 1-fluoronaphthalene (65 L, 0.5 mmol, 1.0 equiv) as an external standard. 
 
General procedure B. An oven-dried 1-dram reaction vial (VWR® glass vials, 66011-041) 
was charged with carboxylic acid (0.5 mmol, 1.0 equiv) and equipped with a PTFE-coated stir 
bar (VWR® Micro stir bars, 2 x 7 mm, 58948-976). The vial was Teflon taped on the threads, 
and then taken into a N2-filled glovebox. To the vial was added MeCN (0.5 M), alkene (265 L, 
1.5 mmol, 3.0 equiv) and 2,6-lutidine (58 L, 0.5 mmol, 1.0 equiv). From a stock solution was 
added [Ir] (8.7 mg, 0.01 mmol, 0.017 equiv). Finally, phosphine (171 L, 1.2 mmol, 2.4 equiv) 
was added. The vial was then capped and sealed with electrical tape. The vial was irradiated 
for 24 h in a Photoreactor (800 rpm, 1500 fan speed, 100% light intensity). An aliquot of the 
crude reaction mixture was analzed by 1H-NMR with 1-fluoronaphthalene (65 L, 0.5 mmol, 
1.0 equiv) as an external standard. 
IV. Compound Characterization 
 
A. Starting Material Synthesis 
 
1-chloro-4-(1-phenylvinyl)benzene (S33) was prepared on a 23.08 mmol scale according to 
a published literature procedure.2 The title compound was isolated using automated column 
chromatography eluting with Hexanes (10 CV). The title compound was concentrated to produce 
a colorless oil (4.05 g, 82% yield). 
1H NMR (500 MHz, CDCl3): δ 7.41 – 7.17 (m, 8H), 5.44 (d, J = 9.1 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 149.11, 141.15, 140.08, 133.72, 129.70, 128.49, 128.41, 128.33, 
128.07, 114.85. 
 
 
1-methyl-4-(1-phenylvinyl)benzene (S34) was prepared on a 12.33 mmol scale according to 
a published literature procedure.2 The title compound was isolated using automated column 
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chromatography eluting with Hexanes (10 CV). The title compound was concentrated to produce 
a colorless oil (2.24 g, 94% yield). 
1H NMR (500 MHz, CDCl3): δ 7.36 (dt, J = 7.1, 3.1 Hz, 5H), 7.30 – 7.25 (m, 2H), 7.17 (d, J = 7.9 
Hz, 2H), 5.45 (d, J = 13.3 Hz, 2H), 2.40 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 150.03, 141.83, 138.74, 137.66, 129.00, 128.43, 128.29, 128.26, 
127.77, 113.79, 21.32. 
 
 
hex-1-en-2-ylbenzene (S35) was prepared on a 5.28 mmol scale according to a published lit-
erature procedure.2 The title compound was isolated using automated column chromatography 
eluting with Hexanes (10 CV). The title compound was concentrated to produce a colorless oil 
(428 mg, 50% yield). Spectral data were consistent with reported literature values.4 
1H NMR (400 MHz, CDCl3): δ 7.44 – 7.39 (m, 2H), 7.37 – 7.30 (m, 2H), 7.29 – 7.24 (m, 1H), 
5.27 (d, J = 1.6 Hz, 1H), 5.06 (d, J = 1.5 Hz, 1H), 2.51 (t, J = 7.5 Hz, 2H), 1.49 – 1.29 (m, 4H), 
0.91 (t, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 148.93, 141.67, 128.36, 127.37, 126.27, 112.14, 35.22, 30.61, 
22.56, 14.07. 
 
 
7-methoxy-1-methylene-1,2,3,4-tetrahydronaphthalene (S36) was prepared on a 11.35 
mmol scale according to a published literature procedure.2 The title compound was isolated 
using automated column chromatography eluting with Hexanes (10 CV). The title compound 
was concentrated to produce a colorless oil (1.17 g, 59% yield). Spectral data were consistent 
with reported literature values.5 
1H NMR (500 MHz, CDCl3): δ 7.17 (d, J = 2.7 Hz, 1H), 7.03 (d, J = 8.4 Hz, 1H), 6.78 (dd, J = 
8.4, 2.7 Hz, 1H), 5.46 (d, J = 1.3 Hz, 1H), 4.96 (d, J = 1.4 Hz, 1H), 3.82 (s, 3H), 2.79 (t, J = 6.3 
Hz, 2H), 2.53 (ddt, J = 7.7, 4.2, 1.4 Hz, 2H), 1.87 (p, J = 6.3 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 157.86, 143.71, 135.68, 130.26, 130.00, 114.47, 108.67, 108.16, 
55.46, 33.31, 29.77, 24.19. 
 
 
1-chloro-4-(prop-1-en-2-yl)benzene (S38) was prepared on a 32.3 mmol scale according to a 
published literature procedure.2 The title compound was isolated using automated column chro-
matography eluting with Hexanes (10 CV). The title compound was concentrated to produce a 
colorless oil (4.94 g, 100% yield). Spectral data were consistent with reported literature values.3 
1H NMR (400 MHz, CDCl3): δ 7.43 – 7.36 (m, 2H), 7.34 – 7.25 (m, 2H), 5.36 (s, 1H), 5.10 (h, J 
= 1.4 Hz, 1H), 2.14 (d, J = 1.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 142.33, 139.83, 133.33, 128.47, 126.96, 113.10, 21.88. 
 
 
1-bromo-4-(prop-1-en-2-yl)benzene (S39) was prepared on a 11.35 mmol scale according to 
a published literature procedure.2 The title compound was isolated using automated column 
chromatography eluting with Hexanes (10 CV). The title compound was concentrated to produce 
a colorless oil (1.63 g, 72% yield). Spectral data were consistent with reported literature values.3 
1H NMR (400 MHz, CDCl3): δ 7.47 – 7.42 (m, 2H), 7.35 – 7.31 (m, 2H), 5.36 (bs, 1H), 5.10 (p, 
J = 1.5 Hz, 1H), 2.20 – 2.01 (m, 3H). 
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13C NMR (101 MHz, CDCl3): δ 142.38, 140.28, 131.43, 127.31, 121.48, 113.20, 21.83. 
 
 
(R)-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid (S41) was prepared on a 4.03 mmol 
scale according to a published literature procedure.6 The title compound was isolated using 
automated column chromatography eluting with MeOH:DCM (0% 4 CV, 0-10% 10 CV, 10% 6 
CV). The title compound was concentrated to produce a white solid (655 mg, 72% yield).  
1H NMR (500 MHz, ((CD3)2SO): δ 12.37 (s, 1H), 4.17 – 3.81 (m, 1H), 3.69 (s, 1H), 3.17 – 2.76 
(m, 2H), 2.31 (d, J = 9.1 Hz, 1H), 1.90 (d, J = 12.5 Hz, 1H), 1.65 – 1.59 (m, 1H), 1.54 – 1.49 (m, 
1H), 1.39 (s, 9H), 1.38 – 1.28 (m, 1H). 
 
 
 
 
 
Figure S4. Racemic standard of (S41).  
ChiralPak® IC, 10% IPA in Hexanes, 60 min run, 1 mL/min. 
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Figure S5. Enantioenriched carboxylic acid (S41; >99% e.e.). 
ChiralPak® IC, 10% IPA in Hexanes, 60 min run, 1 mL/min. 
 
 
B. Product Characterization 
 
4-(3-oxo-5,5-diphenylpentyl)benzonitrileone (4) was prepared according to the general pro-
cedure A. The title compound was isolated using automated column chromatography eluting 
with Ether:Hexanes (0% 4 CV, 0-5% 12 CV, 10% 3 CV, 15% 2 CV, 20% 2 CV. 25% 5 CV) to 
produce a white solid (116 mg, 68% yield).   
1H NMR (500 MHz, CDCl3): δ 7.49 (d, J = 8.2 Hz, 2H), 7.29 – 7.22 (m, 4H), 7.21 – 7.16 (m, 6H), 
7.12 (d, J = 8.2 Hz, 2H), 4.57 (t, J = 7.7 Hz, 1H), 3.14 (d, J = 7.7 Hz, 2H), 2.84 (t, J = 7.2 Hz, 
2H), 2.65 (t, J = 7.2 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 207.35, 146.75, 143.68, 132.35, 129.26, 128.77, 127.78, 126.70, 
119.13, 110.04, 49.10, 46.29, 44.27, 29.38. 
HRMS: (ESI-TOF) calculated for C24H21NaO+ ([M+Na]+): 362.1515, found: 362.1512.  
FTIR (ATR cm–1): 2923, 2225, 1712, 1605, 1579, 1493, 1450, 1412, 1369, 1241, 1177, 1155, 
1091, 1074, 1030, 822, 748, 696, 625, 607, 550, 474, 425.  
 
 
  
S14 
1,1-diphenyl-5-(4-(trifluoromethyl)phenyl)pentan-3-one (5) was prepared according to the 
general procedure A. The title compound was isolated using automated column chromatography 
eluting with Ether:Hexanes (0% 4 CV, 0-10% 10 CV, 10% 10 CV) to produce a white solid (121 
mg, 63% yield).   
1H NMR (400 MHz, CDCl3): δ 7.53 (d, J = 7.8 Hz, 2H), 7.35 – 7.29 (m, 4H), 7.28 – 7.17 (m, 8H), 
4.65 (t, J = 7.6 Hz, 1H), 3.20 (d, J = 7.7 Hz, 2H), 2.90 (t, J = 7.3 Hz, 2H), 2.70 (t, J = 7.3 Hz, 2H). 
13C NMR (126 MHz, CD2Cl2): δ 207.50, 145.95 (d, J = 1.5 Hz), 129.10, 128.95, 128.37 (appd, J 
= 32.2 Hz), 127.96, 126.81, 125.57 (q, J = 3.8 Hz), 124.83 (q, J = 271.7 Hz), 48.96, 46.39, 44.54, 
29.41. Note: Carbon peaks for this compound are overlaping, so assignment is missing one 
carbon peak.   
Note: HSQC NMR of (5) in CD2Cl2.  
 
  
19F NMR (282 MHz, CDCl3): δ -62.39.  
HRMS: (ESI-TOF) calculated for C24H21F3NaO+ ([M+Na]+): 405.1437, found: 405.1435.  
FTIR (ATR cm–1): 3027, 1713, 1617, 1599, 1494, 1450, 1417, 1322, 1161, 1109, 1065, 1030, 
1017, 907, 825, 791, 729, 697, 648, 617, 603, 573, 554, 516, 471, 413. 
 
 
methyl 4-(3-oxo-5,5-diphenylpentyl)benzoate (6) was prepared according to the general pro-
cedure A. The title compound was isolated using automated column chromatography eluting 
with Ether:Hexanes (0% 7 CV, 0-5% 12 CV, 5% 2 CV, 5-10% 4 CV, 10% 2 CV, 15% 8 CV) to 
produce a white solid (121 mg, 65% yield). 
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1H NMR (500 MHz, CDCl3): δ 7.96 (d, J = 8.3 Hz, 2H), 7.36 – 7.30 (m, 4H), 7.30 – 7.21 (m, 6H), 
7.20 – 7.15 (m, 2H), 4.65 (t, J = 7.6 Hz, 1H), 3.96 (s, 3H), 3.21 (d, J = 7.6 Hz, 2H), 2.89 (t, J = 
7.4 Hz, 2H), 2.71 (t, J = 7.4 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 207.68, 167.14, 146.56, 143.79, 129.89, 128.73, 128.43, 128.12, 
127.78, 126.62, 52.15, 49.12, 46.19, 44.59, 29.40. 
HRMS: (ESI-TOF) calculated for C25H25O3+ ([M+H]+): 373.1798, found: 373.1794.  
FTIR (ATR cm–1): 1703, 1607, 1435, 1277, 1255, 1179, 1104, 1093, 1076, 1030, 1019, 986, 
757, 749, 727, 699, 628, 606, 571, 551, 511, 486, 471. 
 
 
5-(4-fluorophenyl)-1,1-diphenylpentan-3-one (7) was prepared according to the general pro-
cedure A. The title compound was isolated using automated column chromatography eluting 
with Ether:Hexanes (0% 4 CV, 0-10% 10 CV, 10% 12 CV) to produce a yellow white solid (123 
mg, 74% yield).  
1H NMR (500 MHz, CDCl3): δ 7.36 – 7.29 (m, 5H), 7.28 – 7.21 (m, 5H), 7.10 – 7.03 (m, 2H), 
7.01 – 6.93 (m, 2H), 4.65 (t, J = 7.6 Hz, 1H), 3.20 (d, J = 7.6 Hz, 2H), 2.82 (t, J = 7.4 Hz, 2H), 
2.68 (t, J = 7.4 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 207.99, 161.44 (d, J = 243.7 Hz), 143.88, 136.67 (d, J = 3.2 Hz), 
129.79 (d, J = 7.8 Hz), 128.74, 127.83, 126.62, 115.30 (d, J = 21.1 Hz), 49.21, 46.17, 45.21 (d, 
J = 1.1 Hz), 28.67. 
19F NMR (282 MHz, CDCl3): δ -117.39. 
HRMS: (ESI-TOF) calculated for C23H22FO+ ([M+H]+): 333.1649, found: 333.1643.  
FTIR (ATR cm–1): 1701, 1660, 1593, 1509, 1355, 1344, 1253, 1220, 836, 812, 749, 701. 
 
 
5-(4-methoxyphenyl)-1,1-diphenylpentan-3-one (8) was prepared according to the general 
procedure A. The title compound was isolated using automated column chromatography eluting 
with Ether:Hexanes (0% 4 CV, 0-10% 10 CV, 10% 7 CV) to produce a white solid (140 mg, 81% 
yield).   
1H NMR (500 MHz, CDCl3): δ  7.35 – 7.30 (m, 4H), 7.27 – 7.20 (m, 6H), 7.06 – 7.03 (m, 2H), 
6.86 – 6.82 (m, 2H), 4.66 (t, J = 7.6 Hz, 1H), 3.83 (s, 3H), 3.19 (d, J = 7.5 Hz, 2H), 2.79 (t, J = 
7.5 Hz, 2H), 2.69 – 2.62 (m, 2H). 
13C NMR (126 MHz, CDCl3): δ 208.30, 158.00, 143.96, 133.07, 129.31, 128.70, 127.83, 126.55, 
113.96, 55.36, 49.20, 46.10, 45.43, 28.70. 
HRMS: (ESI-TOF) calculated for C24H24NaO2+ ([M+Na]+): 367.1668, found: 367.1660.  
FTIR (ATR cm–1):  2915, 1702, 1607, 1580, 1511, 1492, 1464, 1448, 1401, 1366, 1317, 1298, 
1240, 1176, 1091, 1076, 1028, 854, 828, 806, 788, 768, 742, 700, 625, 607, 571, 557, 543, 528, 
518, 468, 436, 408, 401. 
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5-(2-chlorophenyl)-1,1-diphenylpentan-3-one (9) was prepared according to the general pro-
cedure A. The title compound was isolated using automated column chromatography eluting 
with Ether:Hexanes (0% 7 CV, 0-5% 10 CV, 5% 6 CV) to produce a yellow tinted solid (110 mg, 
63% yield).   
1H NMR (500 MHz, CDCl3): δ 7.32 – 7.24 (m, 5H), 7.23 – 7.15 (m, 6H), 7.11 (ddd, J = 12.4, 6.0, 
2.6 Hz, 3H), 4.60 (t, J = 7.6 Hz, 1H), 3.15 (d, J = 7.6 Hz, 2H), 2.89 (t, J = 7.6 Hz, 2H), 2.65 (t, J 
= 7.6 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 207.99, 143.89, 138.61, 133.95, 130.75, 129.62, 128.74, 127.84, 
127.77, 127.01, 126.61, 49.06, 46.28, 43.21, 27.67. 
HRMS: (ESI-TOF) calculated for C23H22ClO+ ([M+H]+): 349.1354, found: 349.1351.  
FTIR (ATR cm–1): 3025, 2931, 2892, 1703, 1599, 1492, 1473, 1445, 1414, 1367, 1305, 1268, 
1232, 1196, 1077, 1050, 1034, 1000, 991, 753, 742, 727, 719, 697, 665, 624, 610, 582, 557, 
523, 483, 457, 436. 
 
 
5-(4,5-diphenyloxazol-2-yl)-1,1-diphenylpentan-3-one (10) was prepared according to the 
general Procedure A using 2.4 equivalents of phosphine and at a concentration of 0.33 M. The 
title compound was isolated using automated column chromatography eluting with Ether:Hex-
anes (0% 5 CV, 5-20% 18 CV, 20% 5 CV) to produce a white solid (228 mg, 34% yield).   
1H NMR (500 MHz, CDCl3): δ 7.63 (d, J = 6.8 Hz, 2H), 7.57 (d, J = 6.9 Hz, 2H), 7.42 – 7.31 (m, 
6H), 7.31 – 7.24 (m, 8H), 7.22 – 7.16 (m, 2H), 4.69 (t, J = 7.5 Hz, 1H), 3.32 (d, J = 7.7 Hz, 2H), 
3.07 (t, J = 7.1 Hz, 2H), 2.97 (t, J = 7.2 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 206.76, 162.31, 145.43, 143.88, 135.12, 132.59, 129.07, 128.72, 
128.66, 128.51, 128.14, 128.00, 127.80, 126.58, 126.55, 49.06, 45.98, 39.76, 22.10. 
Note: Carbon peaks for this compound are overlaping, so assignment is missing one carbon 
peak. 
HRMS: (ESI-TOF) calculated for C32H27NNaO2+ ([M+Na]+): 480.1935, found: 480.1934.  
FTIR (ATR cm–1): 3026, 2921, 1716, 1569, 1493, 1447, 1365, 1264, 1218, 1156, 1094, 1072, 
1057, 1024, 1000, 961, 913, 762, 733, 692, 673, 625, 606, 572, 555, 522, 470. 
 
 
5-(1H-indol-3-yl)-1,1-diphenylpentan-3-one (11) was prepared according to the general pro-
cedure A using 2.4 equivalents of phosphine and at a concentration of 0.33 M. The title com-
pound was isolated using automated column chromatography eluting with Ether:Hexanes (10% 
4 CV, 10-20% 6.8 CV, 20% 10 CV) to produce a yellow white solid (106.2 mg, 60% yield).   
1H NMR (500 MHz, CDCl3): δ 7.88 (bs, 1H), 7.50 (d, J = 7.4 Hz, 1H), 7.33 (d, J = 8.2 Hz, 1H), 
7.29 – 7.24 (m, 4H), 7.21 – 7.16 (m, 7H), 7.14 – 7.02 (m, 1H), 6.78 (d, J = 2.3 Hz, 1H), 4.61 (t, 
J = 7.6 Hz, 1H), 3.15 (d, J = 7.6 Hz, 2H), 2.96 (t, J = 7.6 Hz, 2H), 2.74 (t, J = 7.4 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 208.98, 143.98, 136.31, 128.68, 127.84, 127.18, 126.52, 122.10, 
121.61, 119.36, 118.76, 115.09, 111.25, 49.10, 46.12, 44.05, 19.17. 
HRMS: (ESI-TOF) calculated for C25H23NNaO+ ([M+Na]+): 376.1672, found: 376.1678.  
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FTIR (ATR cm–1): 2360, 1707, 1493, 1455, 1418, 1338, 1264, 1092, 1030, 1010, 731, 697, 608, 
580, 552, 470, 423. 
 
 
1,1-diphenyl-5-(thiophen-2-yl)pentan-3-one (12) was prepared according to the general pro-
cedure A. The title compound was isolated using automated column chromatography eluting 
with EtOAc:Hexanes (0% 4 CV, 1% 4 CV, 1-7% 9 CV, 7% 13 CV) to produce a yellow oil (109 
mg, 68% yield).   
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.24 (m, 4H), 7.23 – 7.15 (m, 6H), 7.09 (dd, J = 5.1, 1.3 
Hz, 1H), 6.87 (dd, J = 5.2, 3.4 Hz, 1H), 6.68 (d, J = 3.4 Hz, 1H), 4.61 (td, J = 7.6, 2.4 Hz, 1H), 
3.17 (dd, J = 7.6, 1.6 Hz, 2H), 3.01 (t, J = 7.4 Hz, 2H), 2.70 (t, J = 7.4 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 207.53, 143.89, 143.66, 128.74, 127.83, 126.94, 126.61, 124.69, 
123.44, 49.18, 46.08, 45.27, 23.75. 
HRMS: (ESI-TOF) calculated for C21H20NaOS+ ([M+Na]+): 343.1127, found: 343.1122.  
FTIR (ATR cm–1): 3025, 2921, 1711, 1598, 1492, 1449, 1406, 1368, 1235, 1091, 1073, 1030, 
1003, 847, 821, 744, 692, 626, 609, 548, 502, 470. 
 
 
5-(2-oxo-4,4-diphenylbutyl)-6,7-dihydrobenzofuran-4(5H)-one (13) was prepared according 
to the general procedure A. The title compound was isolated using automated column chroma-
tography eluting with Ether:Hexanes (0% 4 CV, 0-15% 8 CV, 15% 15 CV) to produce a white 
solid (68 mg, 38% yield). Crude NMR analysis shows a 52% Yield.    
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.21 (m, 9H), 7.20 – 7.15 (m, 2H), 6.62 (d, J = 2.0 Hz, 1H), 
4.62 (t, J = 7.7 Hz, 1H), 3.28 (qd, J = 16.4, 7.7 Hz, 2H), 3.13 (dd, J = 17.6, 4.7 Hz, 1H), 2.96 – 
2.75 (m, 3H), 2.26 (dd, J = 17.6, 7.5 Hz, 1H), 2.04 – 1.96 (m, 1H), 1.71 (tdd, J = 12.9, 11.4, 5.7 
Hz, 1H). 
13C NMR (126 MHz, CDCl3): δ 207.64, 194.82, 166.67, 144.02, 143.85, 142.95, 128.73, 127.93, 
127.86, 126.61, 120.68, 106.83, 49.28, 46.28, 43.15, 42.58, 28.79, 23.49. 
HRMS: (ESI-TOF) calculated for C24H22NaO3+ ([M+Na]+): 381.1461, found: 381.1457.  
FTIR (ATR cm–1): 2922, 2853, 1772, 1713, 1671, 1594, 1579, 1493, 1451, 1372, 1288, 1261, 
1196, 1155, 1117, 1031, 947, 883, 773, 735, 696, 607, 558, 535, 474, 447, 403. 
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Figure S6. Crude NMR Yield for (13). Referenced to one equivalent of 1-fluoronaphthalene. 
 
 
6,6,6-trifluoro-1,1-diphenylhexan-3-one (14) was prepared according to the general proce-
dure A. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 4 CV, 0-4% 9 CV, 6% 7 CV) to produce a yellow oil (93 mg, 61% yield).   
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.26 (m, 4H), 7.24 – 7.16 (m, 6H), 4.59 (t, J = 7.6 Hz, 1H), 
3.21 (d, J = 7.6 Hz, 2H),  2.59 – 2.53 (m, 2H), 2.29 (qt, J = 10.8, 7.7 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 205.37, 143.55, 128.82, 127.73, 126.95 (q, J = 275.8 Hz), 126.77, 
48.90, 46.20, 35.91 (q, J = 2.6 Hz), 27.81 (q, J = 29.9 Hz). 
19F NMR (376 MHz, CDCl3): δ -66.68 (t, J = 10.7 Hz). 
HRMS: (ESI-TOF) calculated for C18H17F3NaO+ ([M+Na]+): 329.1124, found: 329.1126.  
FTIR (ATR cm–1): 3028, 1720, 1597, 1494, 1452, 1439, 1423, 1379, 1314, 1255, 1233, 1195, 
1175, 1134, 1101, 1089, 1001, 983, 927, 850, 823, 794, 746, 726, 696, 627, 602, 565, 538, 469, 
458, 403. 
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1,1-diphenyldecan-3-one (15) was prepared according to the general procedure A. The title 
compound was isolated using automated column chromatography eluting with Ether:Hexanes 
(0% 4 CV, 0-5% 8 CV, 5% 6 CV) to produce a yellow oil (107 mg, 69% yield).   
1H NMR (500 MHz, CDCl3): δ  7.32 – 7.23 (m, 8H), 7.22 – 7.18 (m, 2H), 4.65 (t, J = 7.5 Hz, 1H), 
3.18 (d, J = 7.5 Hz, 2H), 2.33 (t, J = 7.4 Hz, 2H), 1.50 (p, J = 7.3 Hz, 2H), 1.34 – 1.13 (m, 8H), 
0.90 (t, J = 7.0 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 209.30, 144.09, 128.63, 127.84, 126.48, 48.86, 46.08, 43.72, 
31.73, 29.11, 23.62, 22.69, 14.18. 
Note: 13 carbon signals observed due to overlap.  
HRMS: (ESI-TOF) calculated for C22H28NaO+ ([M+Na]+): 331.2032, found: 331.2029.  
FTIR (ATR cm–1): 2924, 2853, 1711, 1493, 1450, 1368, 1068, 1030, 744, 696, 608, 575, 555. 
 
 
tert-butyl (6-oxo-8,8-diphenyloctyl)carbamate (16) was prepared according to the general 
procedure A. The title compound was isolated using automated column chromatography eluting 
with EtOAc:Hexanes (5% 6 CV, 5-20% 10 CV, 20% 7 CV) to produce a white solid (198 mg, 
82% yield).   
1H NMR (500 MHz, CDCl3): δ 7.26 (t, J = 3.7 Hz, 4H), 7.24 – 7.19 (m, 4H), 7.17 (td, J = 6.9, 1.5 
Hz, 2H), 4.59 (t, J = 7.6 Hz, 1H), 4.46 (bs, 1H), 3.14 (d, J = 7.6 Hz, 2H), 3.04 (q, J = 6.8 Hz, 2H), 
2.31 (t, J = 7.2 Hz, 2H), 1.54 – 1.45 (m, 2H), 1.44 (s, 9H) 1.37 (p, J = 7.3 Hz, 2H), 1.14 (p, J = 
7.7 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 209.11, 156.07, 144.03, 128.71, 127.87, 126.58, 79.20, 48.94, 
46.21, 43.54, 40.48, 29.92, 28.57, 26.32, 23.17. 
HRMS: (ESI-TOF) calculated for C25H33NNaO3+ ([M+Na]+): 418.2353, found: 418.2360.  
FTIR (ATR cm–1): 3356, 3026, 2929, 2860, 1697, 1599, 1494, 1450, 1390, 1364, 1246, 1165, 
1064, 1031, 987, 866, 780, 746, 697, 626, 608, 575, 555, 468. 
 
 
7-cyclohexyl-1,1-diphenylheptan-3-one (17) was prepared according to the general proce-
dure B. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 4 CV, 0-10% 10 CV, 10% 10 CV) to produce a slightly yellow tinted white 
solid (149.8 mg, 86% yield) 
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.24 (m, 4H), 7.24 – 7.20 (m, 4H), 7.17 (t, J = 7.2 Hz, 2H), 
4.61 (t, J = 7.6 Hz, 1H), 3.15 (d, J = 7.5 Hz, 2H), 2.30 (t, J = 7.4 Hz, 2H), 1.75 – 1.59 (m, 5H), 
1.44 (p, J = 7.4 Hz, 2H), 1.27 – 1.03 (m, 8H), 0.80 (q, J = 13.9, 12.1 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 209.42, 144.13, 128.68, 127.88, 126.53, 48.93, 46.11, 43.81, 
37.57, 37.30, 33.49, 26.85, 26.54, 26.45, 23.96. 
HRMS: (ESI-TOF) calculated for C25H33O+ ([M+H]+): 349.2526, found: 349.2531.  
FTIR (ATR cm–1):  3027, 1713, 1617, 1599, 1494, 1450, 1417, 1322, 1161, 1109, 1065, 1030, 
1017, 907, 825, 791, 729, 697, 648, 617, 603, 573, 554, 516, 471, 413.  
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(Z)-1,1-diphenylicos-11-en-3-one (18) was prepared according to the general procedure B. 
The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 7 CV, 0-2% 4 CV, 2-7% 5 CV, 7% 7 CV) to produce a yellow oil (223 mg, 
78% yield).   
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.24 (m, 4H), 7.24 – 7.20 (m, 4H), 7.19 – 7.14 (m, 2H), 
5.34 (dq, J = 5.6, 5.0 Hz, 2H), 4.61 (t, J = 7.5 Hz, 1H), 3.15 (d, J = 7.6 Hz, 2H), 2.30 (t, J = 7.4 
Hz, 2H), 2.00 (p, J = 6.9 Hz, 4H), 1.46 (p, J = 7.4 Hz, 2H), 1.38 – 1.09 (m, 20H), 0.88 (t, J = 6.8 
Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 209.35, 144.12, 130.12, 129.91, 128.68, 127.88, 126.53, 48.91, 
46.13, 43.77, 32.05, 29.91, 29.82, 29.67, 29.47, 29.39, 29.22, 29.17, 27.36, 27.31, 23.65, 22.83, 
14.27. 
Note: 23 carbon signals observed due to overlap. 
HRMS: (ESI-TOF) calculated for C32H47O+ ([M+H]+): 447.3621, found: 447.3617. 
FTIR (ATR cm–1): 2921, 2851, 1713, 1493, 1451, 1366, 1064, 1031, 742, 696, 608, 575, 555. 
 
 
 
4,4-diphenylbutan-2-one (19) was prepared according to the general procedure B. The title 
compound was isolated using automated column chromatography eluting with Ether:Hexanes 
(0% 8 CV, 0-8% 12 CV, 15% 3 CV) to produce a yellow oil (86.1 mg, 76% yield).  
1H NMR (500 MHz, CDCl3): δ 7.31 – 7.26 (m, 4H), 7.25 – 7.22 (m, 4H), 7.20 – 7.15 (m, 2H), 
4.60 (t, J = 7.6 Hz, 1H), 3.19 (d, J = 7.5 Hz, 2H), 2.09 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 207.02, 143.96, 128.72, 127.83, 126.58, 49.80, 46.15, 30.81. 
HRMS: (ESI-TOF) calculated for C16H16NaO+ ([M+Na]+): 247.1093, found: 247.1089.  
FTIR (ATR cm–1): 3024, 2926, 1706, 1595, 1583, 1491, 1450, 1407, 1368, 1332, 1249, 1201, 
1162, 1086, 1050, 1031, 1017, 966, 776, 745, 694, 633, 617, 596, 565, 543, 469. 
 
 
5,9-dimethyl-1,1-diphenyldec-8-en-3-one (20) was prepared according to the general proce-
dure B. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 8 CV, 0-7% 10 CV, 7% 3 CV) to produce a pale yellow oil (69 mg, 41% 
yield).   
1H NMR (500 MHz, CDCl3): δ 7.34 – 7.23 (m, 8H), 7.20 (t, J = 7.0 Hz, 2H), 5.06 (t, J = 6.5 Hz, 
1H), 4.64 (t, J = 7.6 Hz, 1H), 3.17 (dd, J = 7.5, 1.6 Hz, 2H), 2.34 (dd, J = 16.0, 5.6 Hz, 1H), 2.16 
(dd, J = 16.0, 8.2 Hz, 1H), 2.07 – 1.80 (m, 3H), 1.70 (s, 3H), 1.60 (s, 3H), 1.27 – 1.18 (m, 1H), 
1.18 – 1.08 (m, 1H), 0.79 (d, J = 6.6 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 208.96, 144.10, 131.56, 128.66, 127.88, 127.87, 126.51, 124.43, 
51.17, 49.39, 46.04, 36.97, 28.78, 25.84, 25.52, 19.73, 17.78. 
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HRMS: (ESI-TOF) calculated for C24H30NaO+ ([M+Na]+): 357.2189, found: 357.2184.  
FTIR (ATR cm–1): 2959, 2913, 1709, 1493, 1449, 1407, 1374, 1060, 1031, 747, 696, 627, 609, 
547, 470. 
 
 
(3aS,4S,6aR)-4-(5-oxo-7,7-diphenylheptyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 
(21) was prepared according to the general procedure B in DMA and at 0.25 mmol scale and 
0.25 M concentration and six equivalents of alkene. The title compound was isolated using au-
tomated column chromatography eluting with EtOAc:Hexanes (60% 4CV, 60-100% 10 CV,  
100% 5 CV) followed by (35% MeOH:EtOAc):EtOAc 0-10% 6 CV, 10% 2 CV, 15%% 2 CV, 15-
25% 5 CV, 25% 12 CV) to produce a pale yellow oil with 80% purity. Isolation of authentic prod-
uct was obtained using supercritical fluid chromatography with a ChiralCel AD-H (2 x 25 cm) 
column and the following conditions: 30% EtOH (0.1 DEA)/CO2, 100 bar, 60 mL/min, 220 nm to 
produce a white/yellow semisolid (28 mg, 27% Yield).  Comparison of the crude reaction mixture 
to clean product resulted in 62% crude NMR yield. When using three equivalents of alkene a 
44% crude NMR yield is obtained. 
1H NMR (500 MHz, CDCl3): δ 7.29 – 7.24 (m, 4H), 7.23 – 7.20 (m, 4H), 7.17 (t, J = 7.2 Hz, 2H), 
5.66 (s, 1H), 5.26 (s, 1H), 4.59 (t, J = 7.6 Hz, 1H), 4.45 (dd, J = 7.8, 4.9 Hz, 1H), 4.22 (dd, J = 
8.4, 4.6 Hz, 1H), 3.15 (d, J = 7.6 Hz, 2H), 3.06 (td, J = 7.3, 4.5 Hz, 1H), 2.86 (dd, J = 12.8, 4.9 
Hz, 1H), 2.65 (d, J = 12.8 Hz, 1H), 2.34 (t, J = 7.3 Hz, 2H), 1.63 – 1.42 (m, 4H), 1.25 (q, J = 7.8, 
7.3 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 209.22, 163.59, 144.02, 128.71, 127.86, 127.85, 126.56, 61.96, 
60.18, 55.39, 48.89, 46.11, 43.22, 40.65, 28.38, 28.32, 23.38. 
HRMS: (ESI-TOF) calculated for C24H28N2NaO2S+ ([M+Na]+): 431.1764, found: 431.1770.  
FTIR (ATR cm–1): 3234, 2925, 1701, 1493, 1451, 1371, 1330, 1265, 748, 701, 608. 
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Figure S7. Crude NMR Yield for (21). Referenced to one equivalent of 1-fluoronaphthalene. 
 
 
Benzyl (S)-2-((tert-butoxycarbonyl)amino)-4-oxo-6,6-diphenylhexanoate (22) was pre-
pared according to the general procedure A and at a 0.25 M concentration. The title compound 
was isolated using automated column chromatography eluting with Ether:Hexanes (0% 4 CV, 
0-10% 4 CV, 10% 6 CV, 10-25% 6 CV, 25% 10 CV) to produce a slightly yellow tinted white 
solid (79 mg, 32% Yield). 
1H NMR (500 MHz, CDCl3): δ 7.34 – 7.31 (m, 3H), 7.27 – 7.22 (m, 6H), 7.20 – 7.14 (m, 6H), 
5.38 (d, J = 8.8 Hz, 1H), 5.10 (d, J = 12.3 Hz, 1H), 5.00 (d, J = 12.3 Hz, 1H), 4.54 (t, J = 7.5 Hz, 
1H), 4.46 (dt, J = 8.7, 4.4 Hz, 1H), 3.28 – 3.04 (m, 3H), 2.86 (dd, J = 18.1, 4.2 Hz, 1H), 1.40 (s, 
9H). 
13C NMR (126 MHz, CDCl3): δ 207.07, 171.27, 155.62, 143.65, 143.61, 135.48, 128.78, 128.74, 
128.65, 128.44, 128.29, 127.77, 126.70, 126.67, 80.08, 67.38, 49.62, 48.88, 45.89, 45.20, 
28.41. 
HRMS: (ESI-TOF) calculated for C30H34NO5+ ([M+H]+): 488.2432, found: 488.2424.  
FTIR (ATR cm–1): 1712, 1495, 1453, 1367, 1336, 1264, 1160, 1074, 1025, 731, 697, 607, 493. 
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Figure S8. HPLC trace of benzyl (S)-2-((tert-butoxycarbonyl)amino)-4-oxo-6,6-diphenylhexano-
ate (93% e.e.).  
ChiralPak® IC, 10% IPA in Hexanes, 60 min run, 1 mL/min. 
 
 
 
 
 
Figure S9. HPLC trace of benzyl (R)-2-((tert-butoxycarbonyl)amino)-4-oxo-6,6-diphenylhexano-
ate (95% e.e.).  
ChiralPak® IC, 10% IPA in Hexanes, 60 min run, 1 mL/min. 
 
 
 
 
 
 
5-(1-(4-bromophenyl)-3-(4-chlorophenyl)-1H-pyrazol-4-yl)-1,1-diphenylpentan-3-one (23) 
was prepared according to the general Procedure A using 2.4 equivalents of phosphine and at 
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a concentration of 0.33 M. The title compound was isolated using automated column chroma-
tography eluting with Ether:Hexanes (0% 5 CV, 0-10% 6 CV, 10-13% 2 CV, 13-25% 4 CV, 25% 
5 CV) to produce a white solid (142.8 mg, 50% yield in 91% purity which corresponds to an 
isolated yield of 45%). Crude NMR analysis shows a 50% Yield.    
1H NMR (500 MHz, CDCl3): δ 7.65 – 7.42 (m, 6H), 7.42 – 7.34 (m, 2H), 7.29 – 7.10 (m, 11H), 
4.58 (t, J = 7.7 Hz, 1H), 3.13 (d, J = 7.6 Hz, 2H), 2.85 (t, J = 7.0 Hz, 2H), 2.63 (t, J = 7.0 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 207.93, 150.58, 143.72, 138.98, 134.06, 132.50, 131.91, 129.14, 
128.96, 128.74, 127.76, 126.83, 126.68, 120.52, 120.29, 119.50, 48.97, 46.26, 43.81, 18.25. 
HRMS: (ESI-TOF) calculated for C32H27BrClN2O+ ([M+H]+): 569.0989, found: 569.0983. 
FTIR (ATR cm–1): 1738, 1492, 1450, 1353, 1269, 1155, 1092, 1077, 1009, 984, 955, 902, 874, 
831, 790, 765, 694, 603, 552, 503. 
 
 
 
Figure S10. Crude NMR Yield for (23). Referenced to one equivalent of 1-fluoronaphthalene. 
 
 
1-(cyclohex-3-en-1-yl)-3,3-diphenylpropan-1-one (24) was prepared according to the general 
procedure B. The title compound was isolated using automated column chromatography eluting 
with Ether:Hexanes (0% 8 CV, 0-5% 12 CV, 5% 10 CV) to produce a pale yellow oil (75 mg, 
51% yield in 94% purity which corresponds to an isolated yield of 48%).   
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1H NMR (500 MHz, CDCl3): δ 7.33 – 7.23 (m, 8H), 7.22 – 7.17 (m, 2H), 5.67 (s, 2H), 4.68 (t, J 
= 7.5 Hz, 1H), 3.26 (p, J = 9.3 Hz, 2H), 2.54 (dddd, J = 11.7, 9.1, 5.9, 2.8 Hz, 1H), 2.10 – 1.98 
(m, 4H), 1.89 – 1.76 (m, 1H), 1.55 – 1.44 (m, 1H). 
13C NMR (126 MHz, CDCl3): δ 211.43, 144.25, 144.22, 128.66, 127.91, 127.90, 126.75, 126.51, 
125.41, 47.22, 47.10, 45.86, 26.66, 24.76, 24.39. 
HRMS: (ESI-TOF) calculated for C21H22NaO+ ([M+Na]+): 313.1563, found: 313.1563.  
FTIR (ATR cm–1): 3024, 2921, 1707, 1493, 1450, 1436, 1373, 1103, 1031, 747, 732, 698, 648, 
611. 
Note: HMBC NMR of (24). Peaks centered at 127.90 and 127.91 are diastereotopic carbons.  
 
 
tert-butyl 4-(3,3-diphenylpropanoyl)piperidine-1-carboxylate (25) was prepared according 
to the general procedure A. The title compound was isolated using automated column chroma-
tography eluting with Ether:Hexanes (0% 4 CV, 0-8% 8 CV, 8% 2 CV, 8-12% 2 CV, 15% 15 CV) 
to produce a white solid (157 mg, 80% yield).  
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.23 (m, 4H), 7.23 – 7.14 (m, 6H), 4.62 (t, J = 7.4 Hz, 1H), 
4.01 (bs, 2H), 3.20 (d, J = 7.5 Hz, 2H), 2.70 (t, J = 12.2 Hz, 2H), 2.35 (tt, J = 11.2, 3.7 Hz, 1H), 
1.65 (bs, 2H), 1.43 (s, 9H), 1.42 – 1.32 (m, 2H).  
13C NMR (126 MHz, CDCl3): δ 210.16, 154.75, 144.03, 128.71, 127.85, 126.61, 79.74, 49.25, 
46.96, 45.82, 29.85, 28.55, 27.23. 
HRMS: (ESI-TOF) calculated for C25H31NNaO3+ ([M+Na]+): 416.2196, found: 416.2200.  
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FTIR (ATR cm–1): 2925, 2848, 1706, 1688, 1494, 1450, 1420, 1383, 1365, 1335, 1308, 1276, 
1248, 1232, 1159, 1129, 1079, 1064, 1028, 1014, 980, 950, 921, 906, 869, 791, 770, 747, 702, 
694, 650, 629, 594, 555, 540, 471. 
 
 
tert-butyl 3-(3,3-diphenylpropanoyl)azetidine-1-carboxylate (26) was prepared according to 
the general Procedure A using 2.4 equivalents of phosphine and at a concentration of 0.33 M. 
The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 4 CV, 0-25% 10 CV, 25% 20 CV) to produce a slightly yellow tinted white 
solid (92 mg, 50% Yield).   
1H NMR (500 MHz, CDCl3): δ 7.31 – 7.26 (m, 4H), 7.24 – 7.12 (m, 6H), 4.61 (t, J = 7.5 Hz, 1H), 
4.00 – 3.75 (m, 4H), 3.30 (p, J = 7.7 Hz, 1H), 3.17 (d, J = 7.5 Hz, 2H), 1.40 (s, 9H). 
13C NMR (126 MHz, CDCl3): δ 206.32, 156.25, 143.61, 128.84, 127.74, 126.81, 79.91, 50.30, 
47.31, 45.95, 39.15, 28.46. 
HRMS: (ESI-TOF) calculated for C23H27NNaO3+ ([M+Na]+): 388.1883, found: 388.1876.  
FTIR (ATR cm–1): 2972, 2929, 2887, 1714, 1697, 1598, 1492, 1474, 1448, 1404, 1368, 1342, 
1296, 1251, 1163, 1129, 1102, 1083, 1070, 1031, 983, 958, 904, 862, 792, 770, 751, 730, 697, 
628, 614, 587, 568, 543, 494, 470, 414. 
 
 
1-cyclopropyl-3,3-diphenylpropan-1-one (27) was prepared according to the general proce-
dure B. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 8 CV, 0-5% 12 CV, 5% 5 CV) to produce a white solid (88.7 mg, 70% yield 
in 92% purity which corresponds to an isolated yield of 65%).   
1H NMR (500 MHz, CDCl3): δ 7.35 – 7.25 (m, 8H), 7.21 (qd, J = 7.0, 6.6, 1.7 Hz, 2H), 4.67 (t, J 
= 7.4 Hz, 1H), 3.34 (dd, J = 7.5, 1.7 Hz, 2H), 1.93 (tt, J = 8.2, 4.7 Hz, 1H), 0.96 – 0.83 (m, 2H), 
0.81 (dd, J = 7.7, 3.6 Hz, 2H). 
13C NMR (126 MHz, CDCl3): δ 208.99, 144.17, 128.64, 127.92, 126.48, 49.72, 46.23, 21.24, 
10.90. 
HRMS: (ESI-TOF) calculated for C18H19O+ ([M+H]+): 251.1430, found: 251.1426.  
FTIR (ATR cm–1): 3025, 3003, 2892, 1694, 1596, 1492, 1449, 1412, 1386, 1362, 1244, 1193, 
1095, 1070, 1044, 1019, 999, 982, 958, 904, 866, 789, 780, 751, 736, 702, 692, 626, 612, 592, 
575, 564, 548, 504, 465. 
 
1-cyclobutyl-3,3-diphenylpropan-1-one (28) was prepared according to the general proce-
dure B. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 8 CV, 0-5% 12 CV, 5% 2.5 CV) to produce a white solid (99 mg, 74% yield).  
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1H NMR (500 MHz, CDCl3): δ 7.28 – 7.24 (m, 4H), 7.23 – 7.20 (m, 4H), 7.17 (td, J = 7.0, 1.5 Hz, 
2H), 4.62 (t, J = 7.5 Hz, 1H), 3.15 (p, J = 8.5 Hz, 1H), 3.09 (d, J = 7.5 Hz, 2H), 2.10 – 1.99 (m, 
4H), 1.94 – 1.83 (m, 1H), 1.75 – 1.66 (m, 1H). 
13C NMR (126 MHz, CDCl3): δ 209.77, 144.24, 128.67, 127.88, 126.51, 46.39, 46.02, 45.87, 
24.11, 17.72. 
HRMS: (ESI-TOF) calculated for C19H21O+ ([M+H]+): 265.1587, found: 265.1593.  
FTIR (ATR cm–1): 2987, 2941, 2860, 1705, 1596, 1493, 1451, 1415, 1376, 1341, 1248, 1120, 
1029, 985, 920, 907, 794, 747, 738, 696, 628, 612, 570, 546, 471. 
 
1-cyclopentyl-3,3-diphenylpropan-1-one (29) was prepared according to the general proce-
dure B. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 10 CV, 0-1% 3 CV, 1-5% 8 CV, 5% 2 CV) to produce a white solid (62 mg, 
52% yield).  
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.16 (m, 8H), 7.20 – 7.13 (m, 2H), 4.64 (t, J = 7.5 Hz, 1H), 
3.20 (d, J = 7.5 Hz, 2H), 2.82 – 2.73 (m, 1H), 1.70 (dtd, J = 12.1, 8.8, 5.3 Hz, 2H), 1.63 – 1.46 
(m, 6H). 
13C NMR (126 MHz, CDCl3): δ 211.09, 144.31, 128.64, 127.92, 126.47, 52.10, 48.14, 45.92, 
28.62, 26.02. 
HRMS: (ESI-TOF) calculated for C20H23O+ ([M+H]+): 279.1743, found: 279.1750.  
FTIR (ATR cm–1): 2960, 1704, 1493, 1450, 1421, 1375, 1089, 1058, 1032, 743, 702, 611, 568, 
547, 471. 
 
 
1-cyclohexyl-3,3-diphenylpropan-1-one (30) was prepared according to the general proce-
dure B. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 8 CV, 0-5% 12 CV, 5% 5 CV) to produce a white solid (87 mg, 59% yield).   
1H NMR (500 MHz, CDCl3): δ 7.28 – 7.23 (m, 4H), 7.24 – 7.20 (m, 4H), 7.19 – 7.14 (m, 2H), 
4.62 (t, J = 7.4 Hz, 1H), 3.19 (d, J = 7.4 Hz, 2H), 2.28 – 2.20 (m, 1H), 1.78 – 1.67 (m, 4H), 1.62 
(d, J = 11.3 Hz, 1H), 1.27 – 1.12 (m, 5H). 
13C NMR (126 MHz, CDCl3): δ 211.92, 144.35, 128.63, 127.92, 126.45, 51.45, 46.97, 45.76, 
28.27, 25.94, 25.73. 
HRMS: (ESI-TOF) calculated for C21H24NaO+ ([M+Na]+): 315.1719, found: 315.1715.  
FTIR (ATR cm–1): 2928, 2849, 1704, 1494, 1450, 994, 748, 697, 628, 613, 587, 554. 
 
 
1-((1r,3s,5R,7S)-3-bromoadamantan-1-yl)-3,3-diphenylpropan-1-one (31) was prepared ac-
cording to the general procedure B. The title compound was isolated using automated column 
chromatography eluting with a 10% Ether Hexanes stock solution:Hexanes (0% 8 CV, 0-10% 
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10 CV, 12% 8 CV, 15% 9 CV, 18% 2 CV, 20% 5 CV) to produce a white solid (100 mg, 47% 
yield).   
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.25 (m, 4H), 7.24 – 7.20 (m, 4H), 7.20 – 7.15 (m, 2H), 
4.65 (t, J = 7.3 Hz, 1H), 3.20 (d, J = 7.3 Hz, 2H), 2.34 – 2.28 (m, 4H), 2.28 – 2.22 (m, 2H), 2.21 
– 2.17 (m, 2H), 1.76 – 1.60 (m, 6H). 
13C NMR (126 MHz, CDCl3): δ 210.38, 144.18, 128.65, 127.89, 126.51, 64.23, 50.95, 48.95, 
48.23, 45.40, 42.84, 36.32, 34.60, 31.78. 
HRMS: (ESI-TOF) calculated for C25H28BrO+ ([M+H]+): 423.1318, found: 423.1314.  
FTIR (ATR cm–1): 2908, 2855, 1697, 1493, 1449, 1306, 1173, 1153, 1132, 1029, 956, 906, 820, 
727, 697, 647, 630, 612, 591, 561, 477. 
 
 
Methyl 4-(3,3-diphenylpropanoyl)bicyclo[2.2.2]octane-1-carboxylate (32) was prepared ac-
cording to the general procedure A. The title compound was isolated using automated column 
chromatography eluting with Ether:Hexanes (0% 8 CV, 0-5% 10 CV, 5% 5 CV, 10% 12 CV) to 
produce a white fluffy solid (50.8 mg, 54% yield).   
1H NMR (500 MHz, CDCl3): δ 7.28 – 7.23 (m, 4H), 7.22 – 7.13 (m, 6H), 4.63 (t, J = 7.3 Hz, 1H), 
3.63 (s, 3H), 3.18 (d, J = 7.3 Hz, 2H), 1.81 – 1.72 (m, 6H), 1.66 – 1.60 (m, 6H). 
13C NMR (126 MHz, CDCl3): δ 212.40, 177.93, 144.34, 128.63, 127.91, 126.46, 51.92, 45.42, 
44.79, 43.78, 39.03, 27.85, 26.93. 
HRMS: (ESI-TOF) calculated for C25H29O3+ ([M+H]+): 377.2111, found: 377.2117.  
FTIR (ATR cm–1): 2947, 2919, 2870, 1720, 1695, 1494,1453, 1432, 1373, 1255, 1237, 1191, 
1077, 1061, 1031, 1004, 905, 841, 795, 761, 751, 727, 704, 696, 628, 611, 570, 549, 470. 
 
 
1-(4-chlorophenyl)-5-(4-fluorophenyl)-1-phenylpentan-3-one (33) was prepared according 
to the general procedure A. The title compound was isolated using automated column chroma-
tography eluting with Ether:Hexanes (0% 8 CV, 0-5% 10 CV, 5% 10 CV) to produce a white 
powdery solid (128 mg, 69% yield).   
1H NMR (400 MHz, CDCl3): δ 7.32 – 7.20 (m, 5H), 7.19 – 7.10 (m, 4H), 7.06 – 7.00 (m, 2H), 
6.96 – 6.89 (m, 2H), 4.58 (t, J = 7.5 Hz, 1H), 3.12 (d, J = 7.5 Hz, 2H), 2.79 (t, J = 7.3 Hz, 2H), 
2.68 – 2.60 (m, 2H). 
13C NMR (126 MHz, CDCl3): δ 207.60, 161.47 (d, J = 243.9 Hz), 143.40, 142.43, 136.56 (d, J = 
2.9 Hz), 132.37, 129.81 (d, J = 7.8 Hz), 129.20, 129.19, 128.84, 127.72, 126.82, 115.33 (d, J = 
21.2 Hz), 49.04, 45.41, 45.19, 28.66. 
19F NMR (376 MHz, CDCl3): δ -117.20 – -117.28 (m). 
HRMS: (ESI-TOF) calculated for C23H20ClFNaO+ ([M+Na]+): 389.1079, found: 389.1078.  
FTIR (ATR cm–1): 2925, 1712, 1600, 1508, 1488, 1451, 1407, 1365, 1305, 218, 1156, 1088, 
1030, 1013, 858, 821, 750, 717, 697, 594, 556, 533, 478, 420. 
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5-(4-fluorophenyl)-1-phfenyl-1-(p-tolyl)pentan-3-one (34) was prepared according to the 
general procedure A. The title compound was isolated using automated column chromatography 
eluting with Ether:Hexanes (0% 7 CV, 0-5% 11 CV, 5% 16 CV) to produce a slightly yellow tinted 
solid (126 mg, 73% yield).   
1H NMR (400 MHz, CDCl3): δ 7.28 – 7.23 (m, 2H), 7.20 – 7.13 (m, 3H), 7.10 – 7.05 (m, 4H), 
7.02 – 6.96 (m, 2H), 6.93 – 6.85 (m, 2H), 4.54 (t, J = 7.6 Hz, 1H), 3.11 (d, J = 7.6 Hz, 2H), 2.75 
(t, J = 7.4 Hz, 2H), 2.60 (t, J = 7.6 Hz, 2H), 2.29 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 208.11, 161.45 (d, J = 243.6 Hz), 144.13, 140.87, 136.71 (d, J = 
3.0 Hz), 136.15, 129.80 (d, J = 7.8 Hz), 129.42, 128.71, 127.76, 127.67, 126.54, 115.28 (d, J = 
21.2 Hz), 49.28, 45.84, 45.20, 28.67, 21.11. 
19F NMR (376 MHz, CDCl3): δ -117.31 – -117.51 (m). 
HRMS: (ESI-TOF) calculated for C24H23FNaO+ ([M+Na]+): 369.1625, found: 369.1631.  
FTIR (ATR cm–1): 1701, 1598, 1508, 1492, 1452, 1417, 1371, 1319, 1258, 1218, 1194, 1157, 
1109, 1078, 1015, 855, 825, 786, 772, 752, 733, 701, 608, 565, 544, 529, 516, 483, 450, 420. 
 
 
1-(4-fluorophenyl)-5-phenylnonan-3-one (35) was prepared according to the general proce-
dure A. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 8 CV, 0-5% 12 CV, 5% 5 CV) to produce a white oil (76 mg, 48% yield).   
1H NMR (500 MHz, CDCl3): δ 7.31 – 7.26 (m, 2H), 7.24 – 7.17 (m, 1H), 7.16 – 7.10 (m, 2H), 
7.01 (dd, J = 8.5, 5.5 Hz, 2H), 6.91 (t, J = 8.7 Hz, 2H), 3.10 (dt, J = 14.7, 7.1 Hz, 1H), 2.80 – 
2.55 (m, 5H), 2.47 (ddd, J = 17.4, 8.4, 6.7 Hz, 1H), 1.62 – 1.48 (m, 2H), 1.35 – 1.00 (m, 4H), 
0.81 (t, J = 7.3 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 209.10, 161.42 (d, J = 243.7 Hz), 144.65, 136.80 (d, J = 3.3 Hz), 
129.79 (d, J = 7.8 Hz), 128.60, 127.60, 126.46, 115.26 (d, J = 21.1 Hz), 50.47, 45.24 (d, J = 1.1 
Hz), 41.50, 36.26, 29.70, 28.72, 22.72, 14.09. 
19F NMR (376 MHz, CDCl3): δ-118.33 (tt, J = 9.0, 4.6 Hz).  
HRMS: (ESI-TOF) calculated for C21H25FNaO+ ([M+Na]+): 335.1782, found: 335.1786.  
FTIR (ATR cm–1): 2954, 2926, 2856, 1711, 1601, 1508, 1494, 1452, 1406, 1367, 1219, 1157, 
1095, 1073, 823, 757, 727, 699, 533, 479, 420. 
 
 
4-(4-fluorophenyl)-1-(7-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butan-2-one (36) was 
prepared according to the general procedure A. The title compound was isolated using auto-
mated column chromatography eluting with Ether:Hexanes (0% 8 CV, 0-5% 10 CV, 5% 18 CV, 
8% 2 CV) to produce a yellow tinted white solid (110 mg, 66% yield). 
1H NMR (500 MHz, CDCl3): δ 7.14 (dd, J = 8.3, 5.5 Hz, 2H), 6.96 (td, J = 8.5, 1.8 Hz, 3H), 6.68 
(dd, J = 8.4, 2.7 Hz, 1H), 6.60 – 6.57 (m, 1H), 3.74 (s, 3H), 3.38 (dq, J = 10.5, 5.6 Hz, 1H), 2.89 
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(t, J = 7.4 Hz, 2H), 2.78 – 2.60 (m, 6H), 1.87 – 1.79 (m, 1H), 1.75 – 1.68 (m, 2H), 1.56 – 1.46 
(m, 1H). 
13C NMR (126 MHz, CDCl3): δ 209.16, 161.52 (d, J = 243.9 Hz), 157.76, 140.97, 136.74 (d, J = 
3.3 Hz), 130.25, 129.90 (d, J = 7.8 Hz), 129.35, 115.38 (d, J = 21.1 Hz), 113.22, 112.21, 55.39, 
50.89, 45.21, 33.52, 29.09, 28.81, 28.43, 19.91. 
19F NMR (376 MHz, CDCl3): δ -117.23 (tt, J = 9.0, 4.9 Hz). 
HRMS: (ESI-TOF) calculated for C21H23FNaO2+ ([M+Na]+): 349.1574, found: 349.1573.  
FTIR (ATR cm–1): 2927, 1709, 1607, 1507, 1463, 1450, 1359, 1278, 1247, 1217, 1156, 1125, 
1096, 1038, 1015, 809, 701, 533, 477. 
 
 
1-(4-fluorophenyl)-5-phenylhexan-3-one (37) was prepared according to the general proce-
dure A. The title compound was isolated using automated column chromatography eluting with 
Ether:Hexanes (0% 4 CV, 0-10% 10 CV, 10% 12 CV) to produce a yellow white solid (97 mg, 
71% yield).  
1H NMR (500 MHz, CDCl3): δ 7.30 (t, J = 7.4 Hz, 2H), 7.24 – 7.17 (m, 3H), 7.06 (dd, J = 8.3, 5.5 
Hz, 2H), 6.94 (t, J = 8.5 Hz, 2H), 3.32 (sx, J = 7.1 Hz, 1H), 2.85 – 2.70 (m, 3H), 2.69 – 2.51 (m, 
3H), 1.26 (d, J = 6.8 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 208.83, 161.42 (d, J = 243.7 Hz), 146.15, 136.76 (d, J = 3.2 Hz), 
129.79 (d, J = 7.8 Hz), 128.66, 126.87, 126.45, 115.27 (d, J = 21.1 Hz), 51.48, 45.11 (d, J = 1.1 
Hz), 35.62, 28.77, 22.09. 
19F NMR (376 MHz, CDCl3): δ -117.33 – -117.46 (m).  
HRMS: (ESI-TOF) calculated for C18H20FO+ ([M+H]+): 271.1493, found: 271.1491.  
FTIR (ATR cm–1): 1601, 1508, 1493, 1451, 1407, 1365, 1218, 1157, 1113, 1095, 1074, 1015, 
822, 760, 698, 532, 478, 422. 
 
5-(4-chlorophenyl)-1-(4-fluorophenyl)hexan-3-one (38) was prepared according to the gen-
eral procedure A. The title compound was isolated using automated column chromatography 
eluting with Ether:Hexanes (0% 8 CV, 0-5% 12 CV, 5-10% 2 CV, 10% 5 CV) to produce a white 
solid (Run 1= 93.9 mg, 61% yield).   
1H NMR (500 MHz, CDCl3): δ 7.30 – 7.25 (m, 2H), 7.16 – 7.11 (m, 2H), 7.10 – 7.04 (m, 2H), 
7.00 – 6.90 (m, 2H), 3.32 (h, J = 7.1 Hz, 1H), 2.82 (t, J = 7.8 Hz, 2H), 2.74 – 2.52 (m, 4H), 1.24 
(d, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 208.45, 161.47 (d, J = 243.8 Hz), 144.64, 136.66 (d, J = 3.3 Hz), 
132.06, 129.81 (d, J = 7.9 Hz), 128.76, 128.30, 115.32 (d, J = 21.2 Hz), 51.33, 45.15, 34.94, 
28.76, 22.08. 
19F NMR (376 MHz, CDCl3): δ -117.17 – -117.30 (m). 
HRMS: (ESI-TOF) calculated for C18H18ClFNaO+ ([M+Na]+): 327.0923, found: 327.0926.  
FTIR (ATR cm–1): 2925, 1712, 1600, 1508, 1488, 1451, 1407, 1365, 1305, 1218, 1156, 1088, 
1030, 1013, 858, 821, 750, 717, 697, 594, 556, 533, 478, 420. 
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5-(4-bromophenyl)-1-(4-fluorophenyl)hexan-3-one (39) was prepared according to the gen-
eral procedure A. The title compound was isolated using automated column chromatography 
eluting with Ether:Hexanes (0% 8 CV, 0-5% 10 CV, 5% 5 CV, 10% 7 CV) to produce a white 
solid (Run 1= 97.9 mg, 56% yield).   
1H NMR (500 MHz, CDCl3): δ 7.42 – 7.35 (m, 2H), 7.05 (dt, J = 8.4, 2.7 Hz, 4H), 6.93 (t, J = 8.7 
Hz, 2H), 3.27 (h, J = 7.0 Hz, 1H), 2.79 (t, J = 7.8 Hz, 2H), 2.70 – 2.50 (m, 4H), 1.21 (d, J = 7.0 
Hz, 3H). 
13C NMR (126 MHz, CDCl3): δ 208.42, 161.48 (d, J = 243.9 Hz), 145.17, 136.66 (d, J = 3.2 Hz), 
131.72, 129.82 (d, J = 7.8 Hz), 128.72, 120.12, 115.34 (d, J = 21.1 Hz), 51.27, 45.16 (d, J = 1.1 
Hz), 35.01, 28.78, 22.03. 
19F NMR (376 MHz, CDCl3): δ -117.23 (tt, J = 8.4, 5.3 Hz). 
HRMS: (ESI-TOF) calculated for C18H18BrFNaO+ ([M+Na]+): 371.0417, found: 371.0420.  
FTIR (ATR cm–1): 3027, 2925, 1712, 1600, 1508, 1488, 1451, 1407, 1365, 1305, 1218, 1156, 
1088, 1030, 1013, 858, 821, 750, 717, 697, 594, 556, 533, 478, 420. 
 
 
1-(4-fluorophenyl)-5-(2-(trifluoromethyl)phenyl)pentan-3-one (40) was prepared according 
to the general procedure A. The title compound was isolated using automated column chroma-
tography eluting with Ether:Hexanes (0% 4 CV, 0-10% 10 CV, 10% 10 CV) to produce a yellow 
white solid (Run 1= 87 mg, 53% yield).   
1H NMR (500 MHz, CDCl3): δ 7.59 (d, J = 7.9 Hz, 1H), 7.42 (t, J = 7.6 Hz, 1H), 7.31 – 7.23 (m, 
2H), 7.13 – 7.06 (m, 2H), 6.93 (t, J = 8.6 Hz, 2H), 3.03 (t, J = 7.8 Hz, 2H), 2.86 (t, J = 7.5 Hz, 
2H), 2.70 – 2.64 (m, 4H). 
13C NMR (126 MHz, CDCl3): δ 208.41, 161.52 (d, J = 243.9 Hz), 139.91 (d, J = 1.9 Hz), 136.65 
(d, J = 3.2 Hz), 132.07, 131.30, 129.86 (d, J = 7.8 Hz), 128.58 (q, J = 29.8 Hz), 126.46, 126.23 
(q, J = 5.7 Hz), 124.68 (q, J = 273.7 Hz), 115.38 (d, J = 21.1 Hz), 44.76, 44.44, 29.05, 26.68 (d, 
J = 1.9 Hz). 
19F NMR (376 MHz, CDCl3): δ -59.76 (s, 3F), -117.22 (tt, J = 9.2, 5.2 Hz, 1F).  
HRMS: (ESI-TOF) calculated for C18H17F4O+ ([M+H]+): 325.1210, found: 325.1213.  
FTIR (ATR cm–1):  2931, 1714, 1607, 1583, 1509, 1453, 1415, 1372, 1311, 1220, 1158, 1113, 
1059, 1037, 1016, 979, 956, 909, 823, 767, 731, 651, 598, 533, 478, 425 
 
 
tert-butyl 3-(3,3-diphenylpropanoyl)piperidine-1-carboxylate (41) was prepared according 
to the general procedure A. The title compound was isolated using automated column chroma-
tography eluting with Ether:Hexanes (0% 6 CV, 0-20% 12 CV, 20% 8 CV) to produce a white 
solid (140 mg, 71% yield).   
1H NMR (500 MHz, CDCl3): δ 7.31 – 7.24 (m, 5H), 7.24 – 7.20 (m, 3H), 7.17 (t, J = 7.3 Hz, 2H), 
4.61 (t, J = 7.4 Hz, 1H), 3.90 (bs, 2H), 3.31 – 3.17 (m, 2H), 2.79 (bs, 1H), 2.70 (bs, 1H), 2.41 
(bs, 1H), 1.81 (bs, 1H), 1.63 (bs, 1H), 1.44 (s, 9H), 1.42 – 1.34 (m, 2H). 
13C NMR (126 MHz, CDCl3): δ 209.45, 154.80, 143.98, 128.72, 128.70, 127.87, 127.81, 126.58, 
79.87, 49.15, 47.56, 45.68, 28.56, 26.67, 24.51. 
HRMS: (ESI-TOF) calculated for C25H31NNaO3+ ([M+Na]+): 416.2196, found: 416.2192.  
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FTIR (ATR cm–1): 2932, 2861,1697, 1653,1495, 1473, 1463, 1451, 1417, 1364, 1348, 1301, 
1290, 1266, 1237, 1106, 1090, 1079, 1060, 1043, 1033, 1015, 996, 960, 940, 918, 889, 866, 
854, 791, 762, 742. 
 
V. Scale Up 
 
 
 
An oven-dried 20 mL reaction vial (Fisher® glass vials, 03-337-15) was charged with Iridium 
(172 mg, 0.017 mmol, 0.017 equiv) and equipped with a PTFE-coated stir bar. The vial was 
Teflon taped on the threads, and then taken into a N2-filled glovebox. To the vial was added 
diphenyl ethylene (5.30 mL, 30 mmol, 3.0 equiv), 2,6-lutidine (1.16 mL, 10 mmol, 1.0 equiv), 
and acetic acid (571 L, 10.0 mmol, 1.0 equiv). Finally, phosphine (3.41 mL, 24 mmol, 2.4 equiv) 
was added. The vial was then capped and sealed with electrical tape. The vial was irradiated 
for 24 h in a Photoreactor (800 rpm, 1500 fan speed, 100% light intensity). An aliquot of the 
crude reaction mixture was analzed by 1H-NMR with 1-fluoronaphthalene (647 L, 5.0 mmol, 
0.5 equiv) as an external standard. Comparison of the crude reaction mixture to clean product 
resulted in a 54% crude NMR Yield. The title compound, 4,4-diphenylbutan-2-one (19) was iso-
lated using automated column chromatography eluting with Ether:Hexanes (0% 15 CV, 0-8% 
12 CV, 15% 3 CV) to produce a yellow oil that solidified into a white solid inside the freezer (1.09 
g, 48% yield). 
 
VI. Mechanistic Studies 
In the course of optimization, differential reactivity was observed between electron neutral and 
electron deficient alkenes in the presence of different phosphines. To probe the origin of this 
reactivity, emission quenching experiments were undertaken to rule out the possibility of com-
petitive electron transfer to the alkenes.    
 
Table S10. Reactivity observed with diphenyl ethylene, alpha methyl styrene, and 1-(trifluoro-
methyl)-2-vinylbenzene in the coupling of 3-(4-fluorophenyl)propanoic acid with triphenyl phos-
phine, ethyl diphenyl phosphinite, and dimethyl phenyl phosphine 
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A. Emission Quenching Experiments 
 
Absorption and Emission experiments were conducted in line with our previous publication on 
the arylation of ethereal C–H bonds.7 An excitation wavelength of 415 nm and an emission 
wavelength of 515 nm were used for monitoring quenching of the iridium photocatalyst. All rea-
gents were prepared in stock solutions inside a nitrogen filled glove box. Reagents were di-
luted in acetonitrile (3 mL) and sealed in a screw-top 1.0 cm quartz cuvette. A blank composed 
of acetonitrile was used in absorbance measurements. Samples for quenching experiment 
were dispensed from a stock solution of Ir[dF(Me)ppy]2(dtbbpy)PF6 (1.314 mM in MeCN, 
amount dispensed: 456 L, 0.6 mol, 2.0x10-4 M after dilution) followed by addition of quench-
ers that were also prepared from stock solutions in MeCN. Absorption spectra were collected 
on an Agilent Technologies Cary 60 UV-Vis Spectrophotometer. Emission quenching data 
were collected on an Agilent Cary Eclipse Fluorescence Spectrophotometer with excitation 
and emissions slit widths of 2.5 and 5 nm were used, respectively.  
 
 
 
 
Figure S11. A. The electronic absorption spectra of Ir[dF(Me)ppy]2(dtbbpy)PF6 at concentra-
tions ranging from 1.0x10-4 to 5.0x10-4 M in MeCN. On the right is the calibration curve for 
Ir[dF(Me)ppy]2(dtbbpy)PF6 at a wavelength of 415 nm ( = 1.149x103 M-1 cm-1).  
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Figure S12. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by 3-(4-fluorophenyl)propanoic acid and 2,6-lutidine. Base and acid were used in a one to one 
stoichiometry. 
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Figure S13. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by diphenyl disulfide.  
 
Our current rationale for the modest boost in yield with diphenyl disulfide is that it is capable of 
oxidizing Ir(II) to regenerate the ground-state Ir(III) photocatalyst.8 This likely increases the con-
centration of phosphine radical cation present in solution. It is possible that disulfide bond ho-
molysis via blue-light irradiation could generate aryl thiyl radicals that are also capable of oxidiz-
ing Ir(II).9       
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Figure S14. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by dimethyl phenyl phosphine. 
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Figure S15. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by tris(4-methoxyphenyl)phosphine. 
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Figure S16. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by diphenyl ethylene. 
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Figure S17. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by ethyl diphenyl phosphinite. 
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Figure S18. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by triphenyl phosphine. 
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Figure S19. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by 1-(trifluoromethyl)-2-vinylbenzene. 
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Figure S20. Characteristic plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 (2.0x10-4 M) emission quenching 
by the reaction mixture. Aliquots of the reaction mixture were added relative to phosphine. The 
mixture contained dimethyl phenyl phosphine (2 equiv), 2,6-lutidine (1.0 equiv), 3-(4-fluoro-
phenyl)propanoic acid (1.0 equiv), dipheny disulfide (5 mol%), and diphenyl ethylene (3 equiv).   
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Figure S21. Overlay plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 emission quenching by dimethyl phenyl 
phosphine, diphenyl ethylene, 1-(trifluoromethyl)-2-vinylbenzene, triphenyl phosphine, and ethyl 
diphenyl phosphinite. 
 
 
Figure S22. Overlay plot of Ir[dF(Me)ppy]2(dtbbpy)PF6 emission quenching by the reaction, di-
methyl phenyl phosphine, and diphenyl ethylene. 
 
Based on the Stern-Volmer quenching constants, it is likely that competitive electron transfer 
between dimethyl phenyl phosphine and an alkene takes place during the course of the reaction. 
Moreover, we propose that the higher quenching rate of dimethyl phenyl phosphine to quench 
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the excited state of iridium relative to diphenyl ethylene is crucial for productive chemistry to 
occur. Likewise, the closer proximity of the Stern-Volmer quenching constant of ethyl diphenyl 
phosphinite to 1-(trifluoromethyl)-2-vinylbenzene than diphenyl ethylene leads to an increased 
efficiency in the coupling with 3-(4-fluorophenyl)propanoic acid with 1-(trifluoromethyl)-2-vi-
nylbenzene (Table S10). 
 
B. Deuterium Studies 
General procedure for deuterium experiments. An oven-dried 1-dram reaction vial (VWR® 
glass vials, 66011-041) was charged with carboxylic acid (0.5 mmol, 1.0 equiv) and equipped 
with a PTFE-coated stir bar (VWR® Micro stir bars, 2 x 7 mm, 58948-976). The vial was Teflon 
taped on the threads, and then taken into a N2-filled glovebox. To the vial was added MeCN 
(0.5 M), 1,1-diphenyl ethylene (265 L, 1.5 mmol, 3.0 equiv) and pyridine (40 L, 0.5 mmol, 
1.0 equiv). Pyridine was used instead of 2,6-lutidine to prevent other hydrogen atom transfer 
reagents from interfering with the reaction. From a stock solution was added 
Ir[dF(Me)ppy]2(dtbbpy)PF6 (8.7 mg, 0.01 mmol, 0.017 equiv). Finally, dimethyl phenyl phos-
phine (171 L, 1.2 mmol, 2.4 equiv) was added. The vial was then capped and sealed with 
electrical tape. The vial was irradiated for 24 h in a Photoreactor (800 rpm, 1500 fan speed, 
100% light intensity). An aliquot of the crude reaction mixture was analzed by 1H-NMR with 1-
fluoronaphthalene (65 L, 0.5 mmol, 1.0 equiv) as an external standard. Quantitative carbon 
was used for calculating deuterium incorporation.  
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Figure S23. Crude reaction mixture of acetic acid and diphenyl ethylene in d3-MeCN after 24 
hours.  
 
 
 
 
Figure S24.  A. The reaction of monodeuteroacetic acid with diphenyl ethylene in MeCN. B. The 
reaction of monodeuteroacetic acid with diphenyl ethylene in MeCN with diphenyl disulfide. 
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Figure S25. Crude reaction mixture of monodeuteroacetic acid and diphenyl ethylene after 25 
minutes when diphenyl disulfide is excluded. The crude 1H-NMR using 1-fluoronaphthalene as 
standard reveals 76% deuterium incorporation.  
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Figure S26. Crude reaction mixture of monodeuteroacetic acid and diphenyl ethylene after 25 
minutes when diphenyl disulfide is included. The crude 1H-NMR using 1-fluoronaphthalene as 
standard reveals 86% deuterium incorporation.  
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Figure S27. Crude reaction mixture of monodeuteroacetic acid and diphenyl ethylene after 24 
hours. Phenyl disulfide was included in this reaction. A. The crude 1H-NMR using 1-fluoronaph-
thalene as standard. B. The quantitative 13C-NMR of the secondary alpha C–H bond. C. The 
quantitative 13C-NMR centered about the methine carbon of the product. D. The quantitative 
13C-NMR centered about the primary alpha carbon of the carbonyl. All quantitative carbon sig-
nals show an isotropic shift associated with deuteration. 
 
 
In order to further probe the configurational stability of enolizable C–H bonds in the product, an 
enantioenriched derivative of nipecotic acid was subjected to the reaction conditions (Table 
S11). An erosion of e.e. was measured in the product during the reaction conditions. Notably, 
the enantioenriched ketone maintains the same level of e.e. when cyclohexane carboxylic acid 
is coupled with diphenyl ethylene (Figure S28).       
 
 
 
Table S11. Reaction of an enantioenriched derivative of nipecotic acid with diphenyl ethylene.  
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Figure S28. Reaction between cyclohexane carboxylic acid and diphenyl ethylene with the prod-
uct of nipecotic acid added as an additive.  
 
 
 
  
S52 
Figure S29. Racemic standard of product. ChiralPak® IC, 5% IPA in Hexanes, 60 min run, 1 
mL/min. 
 
 
 
 
 
 
 
 
 
 
 
Figure S30.  Product of enantioenriched acid after 24 h. ChiralPak® IC, 5% IPA in Hexanes, 60 
min run, 1 mL/min. 
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Given the lack of deuterium incorporation when d3-MeCN was used as solvent, and the ob-
served reactivity at enolizable C–H bonds, a reduction/protonation sequence is proposed to 
close the catalytic cycle of this reaction.  
C. CV of PMe2Ph 
Cyclic voltammetry was conducted on a CH Instruments Electrochemical Analyzer (CH1600E). 
In a nitrogen filled glove box, a 1.3 mM solution of PMe2Ph with 0.2 M tetrabutylammonium 
hexafluorophosphate as supporting electrolyte in MeCN was prepared. The solution was re-
moved from the glove box and a cyclic voltammogram was collected under a nitrogen atmos-
phere using a glassy carbon working electrode, a platinum mesh counder electrode, and a sat-
urated calomel reference electrode. 
 
 
Figure S31. Cyclic Voltammogram of PMe2Ph (Scan rate 0.1 Vs-1) shows an irreversible oxida-
tion at Ep = 0.51 V vs Fc/Fc+, when ferrocene was used as an external reference (Ep = 0.89 V 
vs SCE).10 
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